SCHEMBL17248249

SCHEMBL17248249

c1ccc(-c2cccc(-n3c4ccccc4c4ccc5c(c6ccccc6n5-c5nc(-c6ccccc6)cc(-c6ccccc6)n5)c43)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
L3MBTL1 Q9Y468 4/20 0.35
KDM4E B2RXH2 2/20 0.35
ATM Q13315 1/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33
PDE10A Q9Y233 1/20 0.33
HSD17B10 Q99714 1/20 0.32
MAPT P10636 2/20 0.32
MAPK1 P28482 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
TET2 Q6N021 1/20 0.31
TET1 Q8NFU7 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21018133 0.95 L3MBTL1 (0.38) GABRG2GABRB3GABRA5GABRA3L3MBTL1
SCHEMBL19769894 0.94 KDM4E (0.37) GABRG2GABRB3GABRA5GABRA3L3MBTL1
SCHEMBL19769897 0.93 KDM4E (0.36) GABRG2GABRB3GABRA5GABRA3L3MBTL1
SCHEMBL19769898 0.93 L3MBTL1 (0.38) GABRG2GABRB3GABRA5GABRA3L3MBTL1
SCHEMBL17248251 0.93 L3MBTL1 (0.40) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL15625697 0.93 L3MBTL1 (0.40) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL12131958 0.93 L3MBTL1 (0.41) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL15181228 0.93 GABRG2 (0.32) GABRG2GABRB3GABRA5GABRA3MEN1
SCHEMBL17809373 0.92 L3MBTL1 (0.34) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL24993999 0.92 MEN1 (0.36) GABRG2GABRB3GABRA5GABRA3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020127165-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-06-25 WO disclosed
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 GABRG2 3647/4885GABRB3 2427/4885GABRA5 2614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.